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Abstract Molecular phylogenetic studies of glutaminyl-tRNA
synthetase suggest that it has relatively recently evolved from the
closely related enzyme glutamyl-tRNA synthetase. We have now
attempted to retrace one of the key steps in this process by
selecting glutaminyl-tRNA synthetase mutants displaying en-
hanced glutamic acid recognition. Mutagenesis of two residues
proximal to the active site, Phe-90 and Tyr-240, was found to
improve glutamic acid recognition 3^5-fold in vitro and resulted
in the misacylation of tRNAGln with glutamic acid. In vivo
expression of the genes encoding these misacylating variants of
glutaminyl-tRNA synthetase reduced cellular growth rates by
40%, probably as a result of an increase in translational error
rates. These results provide the first biochemical evidence that
glutaminyl-tRNA synthetase originated through duplication and
consequent diversification of an ancestral glutamyl-tRNA
synthetase-encoding gene.
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1. Introduction
The aminoacyl-tRNA synthetases are a family of enzymes
whose structure and function are highly conserved in the liv-
ing kingdom [1]. They are largely responsible for the synthesis
of correctly charged aminoacyl-tRNAs, the only known sub-
strate for ribosomal mRNA translation. This function neces-
sitates that they display a high degree of accuracy in identify-
ing their cognate tRNA and amino acid substrates and an
ability to discriminate against non-cognates. For the tRNA
substrate this is achieved through a series of sequence speci¢c
protein-RNA interactions between tRNA and synthetase. The
exchange of these recognition elements between di¡erent
tRNAs or AARSs results in corresponding changes in sub-
strate speci¢city [2,3]. The discrimination of di¡erent amino
acids is potentially more problematic as these molecules are
far smaller and may di¡er by as little as a single methyl group.
These small di¡erences, as for example between isoleucine and
valine, cannot be adequately di¡erentiated by AARSs to re-
duce potential miscoding errors during translation to a level
tolerable during normal cell growth. Thus, the synthetases
responsible for synthesizing the corresponding aminoacyl-
tRNAs posses distinct editing activities which serve to elimi-
nate non-cognate reaction intermediates and products [4].
It is becoming increasingly apparent that direct aminoacyl-
ation, where an aminoacyl-tRNA is made by a single enzyme
able to recognize the correct amino acid and tRNA moieties,
is not the only route for aminoacyl-tRNA synthesis. Gln-
tRNAGln, selenocysteinyl-tRNASec (Sec-tRNASec) and Asn-
tRNAAsn are all synthesized via mischarged tRNA intermedi-
ates in certain organisms [5]. Sec-tRNASec is only known to be
made via the mischarging of tRNASec with Ser, possibly be-
cause of the inability of cysteinyl-tRNA synthetase to discrim-
inate selenocysteine and cysteine [6] which precludes the exis-
tence of a ‘selenocysteinyl-tRNA synthetase’. In contrast,
mischarging pathways for the formation of Gln-tRNAGln
and Asn-tRNAAsn are limited to certain organisms/organelles,
raising the question of why two pathways have persisted
through evolution. The prevailing hypothesis for Gln-
tRNAGln formation, is that the mischarging pathway repre-
sents the ancestral route to this aminoacyl-tRNA, which has
subsequently been replaced by a distinct glutaminyl-tRNA
synthetase (GlnRS) enzyme which evolved from glutamyl-
tRNA synthetase (GluRS; see e.g. [7]). This hypothesis sug-
gests that it should be possible to reverse this process, and
thus improve Glu recognition by GlnRS, via discrete amino
acid replacements in GlnRS. The experimental rationale was
based upon the well-documented ability of aminoacyl-tRNA
synthetases to mischarge non-cognate suppressor tRNAs in
vivo (missense suppression [8]) and the capacity of Escherichia
coli to tolerate the low level of translational errors associated
with this process.
In order to both address the question of GlnRS evolution
and to gain insights into the rationale underlying the
phylogenetic distribution of the direct and indirect pathways
for Gln-tRNAGln formation, a genetic screen was established
for amino acid mischarging using a non-essential target
protein. This allowed the isolation of GlnRS mutants which
were able to form Glu-tRNAGln both in vivo and in vitro.
Biochemical and physiological analysis of these variants
suggested that the indirect pathway for Gln-tRNAGln forma-
tion is essential for maintaining the ¢delity of protein syn-
thesis under certain cellular conditions and that this may
provide a basis for the occurrence of the two pathways.
2. Materials and methods
2.1. General
Wild-type [9] and mutant [10] GlnRS proteins, as well as dihydro-
folate reductase (DHFR [11]), were produced and puri¢ed as previ-
ously described. tRNAGln2 was a gift from J.M. Sherman, tRNA
Gln
1
and tRNAGlu were purchased from Subriden RNA (Rolling Bay,
WA). Media for bacterial growth and molecular biology protocols
were standard unless otherwise noted [12].
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2.2. Strains and plasmids
The E. coli strains CC101 (lacZ UAG461 ; [13]), HAPPY101 [10] and
UT172 [14] have been described previously. The 2 kb DraI fragment
containing the glnS gene (which encodes GlnRS) with EcoRI linker
[15] was cloned into the EcoRI site of the pBluescript vectors pKS3
and pKS to prepare single-stranded DNA for enzymatic mutagene-
sis. To construct compatible plasmids containing the amber suppres-
sor tRNA genes, the PvuII fragments of pGFIB-supF G73 [16] or
pGFIB-supE [17] which carry the tRNATyrCUA G73 and tRNA
Gln
CUA genes
respectively, were subcloned into the HincII site of pACYC184. Plas-
mid pD3am contains the coding region of the E. coli DHFR gene fol
with an amber mutation at residue 3, under control of the tac pro-
moter [18]. The pD3am-supFG73 plasmid was constructed by subclon-
ing the PvuII fragments of pGFIB-supFG73, which carry the gene
encoding tRNATyrCUA G73, into pD3am which had been digested with
BamHI and ¢lled using Klenow fragment.
2.3. In vitro mutagenesis and screening of glnS
To allow screening for GlnRS mutants which mischarge tRNATyrCUA
with glutamic acid in vivo, the two dinucleotide binding domains [19]
encoded in the glnS gene were randomly mutagenized using enzymatic
methods [20]. For the enzymatic misincorporation reaction, two syn-
thetic primers (5P-CGATGAAGATTTGGCCAGTGGTAAG-3P and
5P-GTGTAACCACGTCGACGCAGACC-3P) complementary to re-
gions 5P of the ¢rst and 3P of the second dinucleotide binding domains
respectively, were hybridized with single-stranded glnS DNA sepa-
rately. The primer was extended with Klenow fragment in four sepa-
rate sets of reactions, each of which generates a population of mole-
cules terminating just before a given type of base, due to limiting
amounts of that nucleotide. After removal of free nucleotides, the
four molecular populations were misincorporated with three wrong
nucleotides by reverse transcriptase under conditions where proof-
reading does not occur. The four mutagenized molecules were mixed
and completed with excess amounts of dNTPs by polymerase and
ligase. The ligation mixture and pACYC-supFG73 DNA were co-
transformed into strain CC101 and plated on MacConkey plates con-
taining ampicillin and chloramphenicol. After 1 or 2 days of incuba-
tion at 30‡C plasmid DNA was isolated from pink colonies, retested
for the phenotype and identi¢ed by sequencing. Site-directed muta-
genesis was carried out by PCR as previously described [21].
2.4. Chemicals
All chemicals were of analytical quality. L-Glutamic acid (Sigma,
St. Louis, MO) contained no detectable glutamine as determined
by anion exchange amino acid analysis (M. Crawford, Keck Biotech-
nology Laboratory, Yale University, New Haven, CT). L-[U-
14C]Glutamic acid was from NEN-DuPont (Boston, MA) and con-
tained no glutamine as assessed by thin layer chromatography (A.W.
Curnow, personal communication). Methotrexate resin for the a⁄nity
puri¢cation of DHFR was from Sigma (St. Louis, MO).
2.5. Aminoacylation assays
Aminoacylation assays to determine the kinetic parameters for glu-
tamine were performed as described before [9]. Inhibition constants
(Ki) for glutamic acid were determined by standard methods [22].
2.6. Electrophoresis of aminoacylated tRNAs
Aminoacylation of tRNAs with Glu by GlnRS was performed in
100 mM HEPES, pH 7.2, 10 mM MgCl2, 5 mM ATP, 0.1 mg/ml
bovine serum albumin, 5 WM tRNA, 500 nM GlnRS and 1^8 mM
L-[14C]glutamic acid. Following incubation at 20‡C for 1 h, amino-
acylated tRNAs were prepared as previously described [23] except that
they were ¢nally resuspended in sample bu¡er and electrophoresed
using the method of Varshney et al. [24] modi¢ed as described [25].
3. Results
3.1. Isolation of GlnRS variants with improved Glu recognition
The regions of the glnS gene mutated correspond to resi-
dues 24 to approximately 124 and 194 to approximately 294,
which includes all the domains of GlnRS implicated in amino
acid binding from structural studies [26]. Sequencing of mu-
tant glnS genes revealed two changes which gave rise to im-
proved Glu recognition, as assessed by their ability to actively
suppress the lacZ461 mutation in E. coli strain CC101 in the
presence of both a cognate and a non-cognate amber suppres-
sor tRNA. These were C-U at nucleotide 352 which results in
a Phe-Leu change at residue 90 (F90L), and C-A at nucleotide
804 which results in the replacement of Tyr-240 with an in-
frame ochre stop codon (Y240taa; Table 1). To determine the
e¡ect of the second mutation on GlnRS production, a glnS
gene was constructed which lacked the nucleotides encoding
the residues between Tyr-240 and the C-terminus. Expression
of this truncated gene in E. coli strain HAPPY101 gave rise to
a stable protein of the expected molecular weight (determined
by SDS-PAGE and immunoblotting, data not shown) but did
not cause active suppression of lacZ461. Further investigation
of Y240taa production showed the majority of GlnRS was
full length rather than truncated, indicating that the ochre
stop codon is e⁄ciently suppressed. Thus it seems likely that
active suppression of lacZ461 results from substitution of Tyr-
240 with another amino acid in full length GlnRS rather than
by production of a truncated protein. This was later con-
¢rmed by in vitro experiments (see below).
To further investigate the e¡ect of mutating Tyr-240 on
glutamic acid recognition, the codon for this residue was ran-
domly mutagenized and the resulting glnS variants screened
for their ability to actively suppress lacZ461. Sequencing of
positive clones from this screen showed that substitution of
Tyr-240 by either Glu or Gly led to improved glutamic acid
recognition in vivo. Both these and the other GlnRS variants
which showed improved recognition of glutamic acid were
than further analyzed in vitro.
3.2. Kinetic characterization of GlnRS variants with improved
Glu recognition
All the GlnRS variants were puri¢ed from strain HAP-
PY101 as previously described. For the Y240taa mutant a
homogeneous protein of the same molecular weight as wild-
type was isolated. The yield of protein was approximately
¢ve-fold lower than for wild-type in all cases, except for
Y240taa whose yield was ten-fold reduced, indicating that
overproduction of these mischarging mutants is toxic to E.
coli.
The steady state kinetic parameters with respect to Gln
were investigated using the aminoacylation reaction (Table
2). All mutants showed 2^4-fold reduced KMs for Gln com-
pared to wild-type GlnRS, indicating that all the replacements
lead to an apparent increase in the a⁄nity for Gln. kcat values
were 2^3-fold lower for the mutants than for wild-type and
consequently their catalytic e⁄ciencies (as estimated by kcat/
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Table 1
Ability of glnS mutants to suppress lacZ461a
glnS isolate glnS ts complementationb tRNAtyrCUA
a
tRNAGlnCUA
a
Wild-type + 3 3
F90L +/3 + +
Y240taa +/3 + +
Y240E +/3 + n.d.
Y240G +/3 + n.d.
aSuppression was assayed by the ability of transformants to produce
pink colonies due to amber suppression of lacZ461 in strain CC101 at
30‡C. +, pink colonies after 2 days; 3, white colonies after 2 days.
bComplementation of E. coli UT172 (ts) tested after overnight incu-
bation on complete medium at 42‡C. n.d., not determined.
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KM) were little e¡ected, the only exception being Y240taa
which showed a 3-fold increase. Overall these data indicate
that while the replacements a¡ect amino acid binding they are
not detrimental to catalysis.
The ability of mutant and wild-type GlnRSs to recognize
glutamic acid was initially investigated by determining the
kinetic parameters for glutamine in the presence of unlabelled
Glu. Aminoacylation by wild-type GlnRS and all of the mu-
tants was competitively inhibited by Glu. The inhibition con-
stant (KI) for the mutants was 2^5-fold lower than for the
wild-type, with the largest decreases observed for Y240taa
and Y240E GlnRS (Table 2). These results, which indicated
an increase in the apparent a⁄nity of the active sites of the
mutants for glutamic acid, were in agreement with the in vivo
data.
The ability to synthesize Glu-tRNA was then directly inves-
tigated for the two GlnRS mutants originally isolated in vivo,
F90L and Y240taa. To determine whether the mutants could
synthesize glutamylated tRNA, aminoacylation reactions were
performed with radiolabelled glutamic acid at concentrations
up to 8 mM. Despite the use of various reaction conditions,
no signi¢cant level of product could be detected by scintilla-
tion counting. The reaction products were therefore analyzed
by polyacrylamide gel electrophoresis (Fig. 1). The level of
radiolabelled charged tRNA was shown to be dependent on
the glutamic acid concentration, con¢rming that both wild-
type and mutant GlnRS are able to synthesize Glu-tRNAGln.
The amount of product formed was approximately 3-fold
higher for the mutants which broadly correlates with the dif-
ferences in KI compared to wild-type. The tRNA substrate
speci¢city of these mutants was also tested in the presence
of glutamic acid: both were able to use tRNAGln1 and
tRNAGln2 equally well, but neither could use tRNA
Glu (data
not shown).
3.3. E¡ects of tRNA mischarging on protein synthesis and
growth
We attempted to quantify the extent of replacement of glu-
tamine by glutamic acid in proteins during growth in the
presence of Y240taa and F90L GlnRS. This was done by
analyzing the amino acid composition of the third residue
of the DHFR protein expressed from the plasmid pD3am-
supFG73, as previously described [18]. Following N-terminal
sequencing of puri¢ed DHFR, glutamine and tyrosine were
found at a ratio of approximately 10:1 at position 3 in both
cases. This is in agreement with previously determined values
for wild-type GlnRS [16]. Glutamic acid was detected at less
than 10% the level of glutamine and could result from deami-
dation of glutamine during the sequencing reaction. Thus
these experiments show that the actual level of glutamic
acid misincorporation into proteins is less than 5% in these
mutant backgrounds.
The e¡ects of F90L and Y240taa GlnRS on batch growth
kinetics were investigated in the E. coli strain UT172. This
strain contains a mutation in the chromosomal glnS gene
which results in the production of a thermolabile GlnRS
which is unable to sustain growth at 40‡C. The doubling times
of transformants producing wild-type, F90L and Y240taa
GlnRS were measured at 40‡C and 42‡C on LB medium con-
taining either 0.25% or 2.5% NaCl. The higher salt concen-
tration would be expected to cause signi¢cant glutamate ac-
cumulation in the cells due to osmotic adaptation [27,28]. At
low salt concentrations the mutant transformants showed a
40% increase in doubling time at both temperatures compared
to wild-type (Table 3). Growth at higher salt did not e¡ect the
doubling time of wild-type or F90L transformants but did
cause a further 20% increase in the doubling time of the
Y240taa transformant at both temperatures. The level of pro-
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Fig. 1. In vitro aminoacylation of tRNAGln2 with
14C-labeled gluta-
mic acid. Reactions were performed as indicated in the text in the
presence of 8, 4, 2 and 1 mM glutamic acid and the samples then
subjected to PAGE. A: Staining with methylene blue. B: Visualiza-
tion of radiolabeled samples by phosphorimaging.
Table 3
Batch growth parametersa for glnS mutantsb
NaCl (w/v) 40‡C 42‡C
0.25% 2.5% 0.25% 2.5%
glnS Doubling Time (min)
Wild-type 33 þ 2 31 þ 1 52 þ 5 52 þ 4
F90L 46 þ 3 49 þ 3 71 þ 5 72 þ 2
Y240taa 50 þ 2 59 þ 3 64 þ 3 79 þ 6
aDoubling times during the logarithmic phase of batch growth were
measured in triplicate for all cultures (growth medium was LB con-
taining the indicated NaCl concentrations).
bThe E. coli strain UT172 (ts) was transformed with plasmids con-
taining the appropriate glnS gene.
Table 2
Aminoacylation kinetics of GlnRS with Gln in the presence and absence of Glua
GlnRS KM (WM Gln) kcat (min31) kcat/KM (min31 WM31) Kib (mM Glu)
Wild-type 193 þ 21 282 þ 24 1.5 96 þ 20
F90L 50 þ 3 121 þ 4 2.4 29 þ 2
Y240taa 59 þ 5 280 þ 14 4.8 17 þ 2
Y240E 66 þ 7 84 þ 5 1.3 21 þ 5
Y240G 117 þ 15 203 þ 16 1.7 47 þ 8
aAminoacylation experiments were performed at 37‡C in standard bu¡er with Gln levels varied over the range 0.2^5 times KM. Ki values were
determined with unlabeled Glu added at ¢nal concentrations of 20 mM and 40 mM.
bAll enzymes tested displayed competitive inhibition by Glu. Ki was determined from the following formula KMapp = KMreal (1+ [Glu]/Ki).
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duction of full length GlnRS was comparable in all experi-
ments as assessed by immunoblotting (data not shown).
4. Discussion
4.1. Residues proximal to the active site contribute to amino
acid binding
In vitro mutagenesis of the glnS gene followed by in vivo
screening of the encoded mutant proteins identi¢ed residues
Phe-90 and Tyr-240 as being determinants of amino acid spe-
ci¢city. F90L GlnRS showed a 3-fold improvement compared
to wild-type in its ability to recognize glutamic acid, while
replacements of Tyr-240 showed up to 5-fold improvements.
Examination of the kinetic parameters for Y240taa (Table 2)
indicate that this protein is most likely a heterogeneous prep-
aration containing both Y240E and wild-type GlnRS. This
conclusion is based upon the observation that Y240taa dis-
plays a wild-type kcat while the KM for Gln and the Ki for Glu
are nearly identical to Y240E GlnRS. This implies that the
ochre stop codon UAA is suppressed by both tRNATyr and
tRNAGlu species ; while this speci¢c mixed suppression has not
been previously observed, it is consistent with established pat-
terns of stop-codon suppression in E. coli [8].
The crystal structure of GlnRS complexed with tRNAGln2
and the Gln-AMP analogue 5P-O-[N-(L-glutaminyl) sulfamoyl]
adenosine [29] shows Tyr-240 to be close to a number of
residues which determine the speci¢city of glutamine binding
through a network of interactions with the -NH2 group of the
glutamine side chain. While not directly implicated in this
network of interactions, the proximity of Tyr-240 and orien-
tation of its sidechain suggest that it may indirectly contribute
to amino acid speci¢city. This is supported by the observation
that Tyr-240 is conserved in all known GlnRS proteins while
the analogous position in GluRS is not (Fig. 2). A comparable
situation has previously been observed for tyrosine binding by
Bacillus stearothermophilus tyrosyl-tRNA synthetase (TyrRS)
where a number of residues serve to position Asp-176 which
acts as the hydrogen bond acceptor for the para-hydroxyl
group of the substrate tyrosine [30]. Mutation of residues
which interact with Asp-176, but not directly with tyrosine,
was found to lower the ability of TyrRS to discriminate ty-
rosine and phenylalanine.
While mutation of both Phe-90 and Tyr-240 improves glu-
tamic acid recognition, these changes are accompanied by
concomitant improvements in the apparent a⁄nity for the
cognate substrate glutamine suggesting that only minor
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Fig. 2. Partial alignment of GlnRS amino acid sequences. The sequences were aligned using the CLUSTAL W program [36]. The sequences
shown are from lupin (LL), Trichomonas vaginalis (TV), Haemophilus in£uenzae (HI), human (HS), Nosema locustae (NL), Saccharomyces cere-
visiae (SC), Vibrio cholerae (VC), Pseudomonas aeruginosa (PA), Deinococcus radiodurans (DR) and E. coli (EC). The structure-based alignment
of the Thermus thermophilus GluRS protein (TTgltX [37]) is also shown. Amino acids Phe-90 and Tyr-240 of E. coli GlnRS are indicated (*).
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changes in substrate speci¢city have been achieved. This re-
£ects the limitation of the genetic approach employed in this
study: any mutants selected must still retain the ability to
recognize glutamine su⁄ciently better than glutamic acid to
prevent a lethal level of translational errors arising. Site-di-
rected mutagenesis based upon the structure of the active-site
interactions with glutamine [29], in combination with a suit-
able expression strategy, may now provide the best means of
further improving the glutamic acid substrate-speci¢city of
GlnRS.
4.2. Physiological consequences of tRNA mischarging
The replacement of wild-type GlnRS with mischarging mu-
tant proteins in vivo was achieved by complementation of a
temperature sensitive glnS allele under restrictive conditions,
with the resulting transformants growing approximately 40%
slower than wild-type. Since the mutants have comparable
catalytic e⁄ciencies (kcat/KM) to wild-type for Gln-tRNAGln
synthesis, the di¡erence in growth rate is most likely the result
of errors in translation resulting from Glu-tRNAGln synthesis.
The misacylation of tRNAGln with glutamic acid only pro-
ceeds at a low level as indicated by the absence of detectable
glutamic acid at a speci¢c position in the target protein
DHFR. However, increasing the cellular glutamic acid con-
centration by increasing the extracellular salt concentration
[27,28] speci¢cally reduced the growth rate by 20% of trans-
formants containing GlnRS with a Tyr-240 mutation, suggest-
ing that the level of Glu-tRNAGln synthesis, and thus trans-
lational errors, was elevated under these conditions. This
observation correlates with the earlier ¢nding that gram pos-
itive bacteria, which contain signi¢cantly larger cellular gluta-
mic acid pools than gram negative bacteria [27,31], do not
contain GlnRS and instead synthesize Gln-tRNAGln by an
indirect pathway (see below). Taken together, these results
suggest that the ratio of cellular glutamic acid to glutamine
is a major factor in determining the potential substrate spe-
ci¢city of GlnRS and thus its e⁄ciency as a component of the
translational apparatus. Whether this aspect of cellular phys-
iology has acted as an evolutionary pressure to determine the
phylogenetic distribution of GlnRS remains unclear.
4.3. Evolutionary origin of glutaminyl-tRNA synthetase
GlnRS-encoding genes are not found in the majority of
bacteria and organelles, and have not been detected to date
in archaea [5,32]. In these cases, Glu-tRNAGln is ¢rst synthe-
sized by GluRS and this molecule is subsequently converted
to Gln-tRNAGln by a speci¢c amidotransferase [33]. Molecu-
lar phylogenetic analyses suggest that this represents the more
ancient pathway to Gln-tRNAGln, with GlnRS having re-
cently evolved after duplication of GluRS [7,34]. This possi-
bility, rather than separate origins of the two pathways, is
supported by the recent observation that the genome of the
bacterium Deinococcus radiodurans encodes the Glu-tRNAGln
speci¢c amidotransferase, GlnRS and GluRS (Tumbula, Cur-
now, Pelaschier and Soºll, unpublished results).
During its molecular evolution a duplicated ancestral
GluRS would only be required to lose the ability to recognize
tRNAGlu and gain the ability to recognize glutamine instead
of glutamic acid in order to become a functional GlnRS. The
necessary co-evolution of synthetase and tRNA to generate a
functional, speci¢c GlnRS:tRNAGln pair has been discussed
previously [35]. The data shown here now indicate that
changes in the ability to recognize glutamine and glutamic
acid can be achieved by discrete mutations. While the degree
of change in substrate speci¢city was limited by the potential
toxicity of the mutant GlnRS enzymes, this would not have
been the case during evolution as the ‘new’ product would be
Gln-tRNAGln, a suitable substrate for translation.
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